Enanta Pharma (ENTA)
14.08
+0.06 (0.43%)
Upcoming Events
Latest Headlines
Enanta Pharmaceuticals to Participate in September Investor Conferences
September 1, 2026 7:00 AM - BizWire
Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: Deep Track Capital, LP
August 14, 2026 8:26 AM - SEC Filing
Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
August 14, 2026 8:19 AM - SEC Filing
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30
August 12, 2026 7:01 AM - SEC Filing
Form 8-K ENANTA PHARMACEUTICALS For: Aug 10
August 10, 2026 4:06 PM - SEC Filing
Enanta Pharma (ENTA) Misses Q3 EPS by 17c
August 10, 2026 4:02 PM - StreetInsider
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
August 10, 2026 4:01 PM - BizWire
Form 4 ENANTA PHARMACEUTICALS For: Aug 08 Filed by: Rottinghaus Scott T.
August 10, 2026 9:01 AM - SEC Filing
Enanta Pharmaceuticals sets up $75M at-the-market stock offering
July 2, 2026 4:58 PM - StreetInsider
Form 8-K ENANTA PHARMACEUTICALS For: Jul 02
July 2, 2026 4:57 PM - SEC Filing
Form 424B5 ENANTA PHARMACEUTICALS
July 2, 2026 4:54 PM - SEC Filing
Enanta Pharma loses appeal in Pfizer Paxlovid patent case
June 23, 2026 5:30 PM - StreetInsider
Form 8-K ENANTA PHARMACEUTICALS For: Jun 23
June 23, 2026 5:28 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
June 23, 2026 6:52 AM - StreetInsider
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
June 23, 2026 5:10 AM - BizWire
Form 8-K ENANTA PHARMACEUTICALS For: Jun 18
June 18, 2026 7:13 AM - SEC Filing
Enanta advances RSV drug zelicapavir into late-stage trials
June 18, 2026 7:01 AM - StreetInsider
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
June 18, 2026 7:00 AM - BizWire
Full Article List
